不可切除胰腺癌放化疗患者急性和晚期毒性预测因素
该回顾性研究纳入1999至2012年211例局部晚期胰腺癌放化疗患者,探索上消化道出血、短期放疗副作用、失败模式及生存的影响因素。金属胆道支架与上消化道出血风险升高相关(校正HR 17.38),并与死亡风险升高相关(HR 1.99)。调强放疗较三维适形放疗与恶心风险降低相关(OR 0.27)。
核心结论
- 金属胆道支架可能与上消化道出血风险升高和死亡率升高相关。
- 调强放疗较三维适形放疗与更少恶心和短期毒性相关。
研究设计与样本
- 经机构审查委员会批准方案下进行的回顾性研究,纳入1999至2012年211例接受放化疗的局部晚期胰腺癌患者。
- 所有患者接受同步化疗,其中吉西他滨174例、5-氟尿嘧啶27例;67例接受调强放疗。
- 采用统计模型检验临床特征与上消化道出血、放疗中断及治疗期间体重下降等结局之间的关联。
主要发现
- 18例患者发生与治疗相关的上消化道出血,其中70%出血位于胃或十二指肠。
- 上述出血患者中,11例(61%)为胰头肿瘤,17例(94%)置有金属胆道支架。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Patients with pancreatic cancer undergoing chemoradiation therapy may experience acute and chronic side effects. We conducted an exploratory analysis of patients with locally advanced pancreatic cancer (LAPC) undergoing definitive chemoradiation to identify factors influencing the occurrence of gastrointestinal (GI) bleeding, short-term radiation side effects, patterns of failure, and survival. METHODS AND MATERIALS: Under an institutional review board-approved protocol, we retrospectively studied patients with LAPC treated with chemoradiation. Statistical models were used to test associations between clinical characteristics and outcomes, including upper GI bleeding, radiation treatment breaks, and weight loss during therapy. RESULTS: Between 1999 and 2012, 211 patients were treated with radiation for pancreatic cancer. All patients received concurrent chemotherapy with either gemcitabine (174) or 5-fluorouracil (27), and 67 received intensity modulated radiation therapy (IMRT). Overall, 18 patients experienced an upper GI bleed related to treatment, with 70% of bleeds occurring in the stomach or duodenum, and among those patients, 11 (61%) patients had a pancreatic head tumor and 17 (94%) patients had a metallic biliary stent. IMRT was associated with decreased risk of postradiation nausea (odds ratio, 0.27 [0.11, 0.67], P = .006) compared with 3-dimensional conformal radiation. Regarding long-term toxicities, patients with a metallic biliary stent at the time of radiation therapy were at a significantly higher risk of developing upper GI bleeding (unadjusted hazard ratio [HR], 15.41 [2.02, 117.42], P = .008), even after controlling for radiation treatment modality and prescribed radiation dose (adjusted HR, 17.38 [2.26, 133.58], P = .006). Furthermore, biliary stent placement was associated with a higher risk of death (HR, 1.99 [1.41, 2.83], P < .001) after adjusting for demographic, treatment-related, and patient-related variables. CONCLUSIONS: Metallic biliary stents may be associated with an increased risk of upper GI bleeding and mortality. Furthermore, IMRT was associated with less nausea and short-term toxicity compared with 3-dimensional conformal therapy.
引用
- Das R, Abbott MR, Hadley SW, et al. Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer. Adv Radiat Oncol. 2023. PMID: 38047228. doi:10.1016/j.adro.2023.101266
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。